M. Lambert et al., CONSUMPTION PATTERN AND MOTIVATION FOR TH E USE OF PSYCHOTROPIC SUBSTANCES IN SCHIZOPHRENICS, Psychiatrische Praxis, 24(4), 1997, pp. 185-189
In particular studies conducted in the U.S. display a tendency for sch
izophrenics to combine hallucinogens and amphetamines, whereas other s
tudies report on a combination of psychotropic substances with a simil
ar range of action. Influencing negative symptoms is reported to be th
e motivation for consumption. A total of 222 patients with a schizophr
enic disorder (FZ) and addiction (F1) were examined. The main substanc
e was alcohol (F10.1 or F10.2; 52.2%), followed by cannabis (F12; 25%)
, opiates (F11;4.1%), sedatives or hypnotics (F13; 2.7%), and cocaine
(F16; 0.5%). A multiple drug use (F19) is reported by 14% of them. The
most frequent combination was alcohol and cannabis, whereas hallucino
gens and amphetamines were only rarely combined. Actual multiple consu
mption was reported by 55% of the patients, while lifetime multiple co
nsumption applied to 72%. The motivation seems to be an unspecified se
dation of unpleasant affective symptoms of schizophrenia. The most fre
quently seen combinations do not correlate with the reports published
in the literature. The great variations in motivation seem to mainly r
eflect the importance of the availability of the substance.